S0B1073 Invivo Anti-Mouse CD366 (TIM-3) Recombinant mAb
- 公司名稱(chēng) 杭州斯達(dá)特生物科技有限公司
- 品牌 Starter/斯達(dá)特
- 型號(hào) S0B1073
- 產(chǎn)地 浙江 杭州
- 廠商性質(zhì) 生產(chǎn)廠家
- 更新時(shí)間 2025/7/14 19:36:40
- 訪問(wèn)次數(shù) 46
聯(lián)系方式:王修明13774214275 查看聯(lián)系方式
聯(lián)系我們時(shí)請(qǐng)說(shuō)明是化工儀器網(wǎng)上看到的信息,謝謝!
TIM-3 (T cell immunoglobulin and mucin domain-containing protein 3), also known as HAVCR2, is a crucial immune checkpoint molecule that is extensively expressed on various immune cells, including Th1, Th17, Treg, dendritic cells, monocytes, macrophages, and NK cells. The role of TIM-3 in the tumor immune microenvironment is particularly significant, as it is highly expressed on tumor-infiltrating CD8+ T cells and regulatory T cells (Tregs), and is co-expressed with PD-1, participating in the regulation of tumor immune evasion and T cell exhaustion. TIM-3 exerts its immune suppressive function by binding to its ligands, which include galectin-9 (Gal-9), phosphatidylserine (PtdSer), carcinoembryonic antigen-related cell adhesion molecule 1 (CEACAM-1), and high mobility group box 1 (HMGB1). These interactions lead to Th1 cell apoptosis, T cell exhaustion, and immune suppression, thereby facilitating tumor cells to evade immune surveillance. In cancer treatment strategies, TIM-3 has emerged as a promising target. Furthermore, the expression level of TIM-3 correlates with poor prognosis in certain types of cancer, making it a potential prognostic biomarker.
相關(guān)分類(lèi)
該廠商的其他產(chǎn)品
- S0B7003 Invivo anti-mouse CD16/CD32 Recombinant mAb
- S0B7002 Invivo Anti-Mouse CD41 Recombinant mAb (S-R690)
- S0B7000 Invivo Anti-Mouse CD40 Recombinant mAb (S-R456)
- S0B7001 Invivo Anti-Mouse CD200 (OX2) Recombinant mAb (S-R739)
- S0B1459 Invivo anti-mouse PD-1 Recombinant mAb (S-R496)
- S0B1361 Invivo Rat anti-Mouse CD276 Recombinant mAb
- S0B1303 Invivo human IgG4 S228P,kappa isotype control
- S0B1283 Invivo anti-Mouse IL-17A Recombinant mAb